VERTEX PHARMACEUTICALS INC / MA Insider Trading for August 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for August 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 30 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 131.89 | 2,125 | 280,266 | 8,500 | |
| Aug 30 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 181.89 | 2,125 | 386,516 | 39,113 | 41.2 K to 39.1 K (-5.15 %) |
| Aug 30 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 131.89 | 2,125 | 280,266 | 41,238 | 39.1 K to 41.2 K (+5.43 %) |
| Aug 07 2018 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Option Exercise | M | 86.52 | 2,330 | 201,592 | 23,299 | |
| Aug 07 2018 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 174.20 | 2,330 | 405,886 | 39,609 | 41.9 K to 39.6 K (-5.56 %) |
| Aug 07 2018 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Buy | M | 86.52 | 2,330 | 201,592 | 41,939 | 39.6 K to 41.9 K (+5.88 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Option Exercise | M | 86.52 | 1,942 | 168,022 | 19,416 | |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Option Exercise | M | 91.05 | 2,155 | 196,213 | 12,932 | |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 176.69 | 100 | 17,669 | 46,662 | 46.8 K to 46.7 K (-0.21 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 175.86 | 700 | 123,102 | 46,762 | 47.5 K to 46.8 K (-1.47 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 174.50 | 1,142 | 199,279 | 47,462 | 48.6 K to 47.5 K (-2.35 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Buy | M | 86.52 | 1,942 | 168,022 | 48,604 | 46.7 K to 48.6 K (+4.16 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 179.38 | 300 | 53,814 | 46,662 | 47 K to 46.7 K (-0.64 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 178.49 | 355 | 63,364 | 46,962 | 47.3 K to 47 K (-0.75 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 176.95 | 400 | 70,780 | 47,317 | 47.7 K to 47.3 K (-0.84 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 175.88 | 400 | 70,352 | 47,717 | 48.1 K to 47.7 K (-0.83 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 175.06 | 700 | 122,542 | 48,117 | 48.8 K to 48.1 K (-1.43 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Buy | M | 91.05 | 2,155 | 196,213 | 48,817 | 46.7 K to 48.8 K (+4.62 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 86.52 | 2,330 | 201,592 | 23,299 | |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 91.05 | 1,796 | 163,526 | 10,776 | |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 174.20 | 2,330 | 405,886 | 39,113 | 41.4 K to 39.1 K (-5.62 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 86.52 | 2,330 | 201,592 | 41,443 | 39.1 K to 41.4 K (+5.96 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 174.59 | 1,796 | 313,564 | 39,113 | 40.9 K to 39.1 K (-4.39 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 91.05 | 1,796 | 163,526 | 40,909 | 39.1 K to 40.9 K (+4.59 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 86.52 | 809 | 69,995 | 8,090 | |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 91.05 | 1,289 | 117,363 | 7,735 | |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 174.20 | 809 | 140,928 | 16,087 | 16.9 K to 16.1 K (-4.79 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 86.52 | 809 | 69,995 | 16,896 | 16.1 K to 16.9 K (+5.03 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 174.59 | 1,289 | 225,047 | 16,087 | 17.4 K to 16.1 K (-7.42 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 91.05 | 1,289 | 117,363 | 17,376 | 16.1 K to 17.4 K (+8.01 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 86.52 | 1,553 | 134,366 | 15,533 | |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 109.14 | 4,250 | 463,845 | 8,500 | |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 91.05 | 2,155 | 196,213 | 12,931 | |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 131.89 | 2,125 | 280,266 | 8,500 | |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 174.20 | 5,803 | 1,010,883 | 46,752 | 52.6 K to 46.8 K (-11.04 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 86.52 | 1,553 | 134,366 | 52,555 | 51 K to 52.6 K (+3.04 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 109.14 | 4,250 | 463,845 | 51,002 | 46.8 K to 51 K (+9.09 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 174.59 | 2,155 | 376,241 | 46,752 | 48.9 K to 46.8 K (-4.41 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 91.05 | 2,155 | 196,213 | 48,907 | 46.8 K to 48.9 K (+4.61 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 179.00 | 2,125 | 380,375 | 46,752 | 48.9 K to 46.8 K (-4.35 %) |
| Aug 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 131.89 | 2,125 | 280,266 | 48,877 | 46.8 K to 48.9 K (+4.55 %) |